Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   


The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (

Term:red blood cell sodium/potassium passive permeability
go back to main search page
Accession:CMO:0003774 term browser browse the term
Definition:This is a measurement of sodium and/or potassium ion efflux from erythrocytes in the presence of a sodium-potassium pump inhibitor (ouabain) and a sodium-potassium-chloride cotransporter inhibitor (furosemide or bumetamide).
Synonyms:exact_synonym: erythrocyte passive membrane permeability;   erythrocyte sodium/potassium passive permeability;   ouabain and bumetanide-resistant sodium/potassium flux
 xref: PMID:1390856

show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    blood measurement 443
      red blood cell measurement 0
        red blood cell physiological measurement 0
          red blood cell sodium/potassium passive permeability 0
            calculated red blood cell sodium/potassium passive permeability + 0
paths to the root